Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Biotron Limited ( (AU:BIT) ) has provided an announcement.
Biotron Limited has reported a significant increase in profit for the half year ended 31 December 2024, with profits rising by 152.62% to $696,629. Despite the positive financial performance, the company did not declare any dividends for the period, and there is a noted material uncertainty that stakeholders should consider.
More about Biotron Limited
Biotron Limited operates in the biotechnology industry, focusing on the development and commercialization of novel antiviral therapies. The company is primarily engaged in research and development activities aimed at addressing significant unmet medical needs in the market.
YTD Price Performance: 390.0%
Average Trading Volume: 23,250
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $5.05M
For detailed information about BIT stock, go to TipRanks’ Stock Analysis page.